课题基金 / 基金详情

Research & Development of molecular target therapy for leukemia and Its assessment System

Research & Development of molecular target therapy for leukemia and Its assessment System
研究
批准号:
17016029
负责人:
NAOE Tomoki
金额:
$29.38万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2009

项目摘要

项目成果

NAOE Tomoki的其他基金

相似基金

相关文献

中文摘要
翻译
为了开发更有效、更安全的白血病靶向治疗,我们阐明了突变的Flt3和Kit以及嵌合体转录因子PML-RARA招募的N-COR/HDAC3/TBLR1复合体是理想的治疗靶向分子/复合体。我们开发了Flt3抑制剂FI-700和KW-2449,以及KIT抑制剂KI-328。针对N-COR/HDAC3/TBLR1复合体,我们设计了一种诱饵多肽。我们还建立了用流式细胞仪检测白血病细胞p-Flt3或p-STAT5的实验室系统,并建立了药物动力学血浆生物检测系统。
英文摘要
For the development of more effective and secure target therapy for leukemia, we clarified that mutated FLT3 and KIT, and N-CoR/HDAC3/TBLR1 complex that is recruited by chimera transcription factor PML-RARA are ideal target molecules/complex for therapy. We developed FLT3 inhibitors, FI-700 and KW-2449, and KIT inhibitor, KI-328. For targeting N-CoR/HDAC3/TBLR1 complex we designed a decoy peptide. We also established a laboratory system which can evaluate p-FLT3 or p-STAT5 of leukemia cells using FACS and estimate pharmaco-dynamismly plasma bioassay system.
期刊论文(55)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s12185-008-0221-1
发表时间: 2008-12-01
期刊: INTERNATIONAL JOURNAL OF HEMATOLOGY
影响因子: 2.1
作者: [Abe, Akihiro, Minami, Yosuke, Naoe, Tomoki]
通讯作者: Naoe, Tomoki
BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia.
BMI-1 在 M0 亚型急性髓系白血病中高表达。
DOI: --
发表时间: 2005
期刊: Int.J.Hematol. 82
影响因子: --
作者: [Sawa, M., Yamamoto, K., Yokozawa, T., Kiyoi, H., Hishida, A., Kajiguchi, T., Seto, M., Kohno, A., Kitamura, K., Itoh, Y., Asou, N., Hamajima, N., Emi, N., Naoe, T.]
通讯作者: T.
DOI: 10.1002/gcc.20309
发表时间: 2006-04-01
期刊: GENES CHROMOSOMES & CANCER
影响因子: 3.7
作者: [Karnan, S, Tsuzuki, S, Naoe, T]
通讯作者: Naoe, T
FLT3/ITD Regulates Leukemia Cell Adhesion throughα4β1 Integrin and Pyk2 Signalin
FLT3/ITD 通过 α4β1 整合素和 Pyk2 信号蛋白调节白血病细胞粘附
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [Katsumi A, Naoe T, et al.]
通讯作者: et al.
共 43 条
    Translational research toward drug discovery of leukemia
    Development of innovative anti-tumor agents that target signal transducers and activator of transcription
    • 批准号:
      23659487
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      NAOE Tomoki
    • 依托单位:
    Basic research aimed at understanding and overcoming of the primary and secondary resistance in molecular target therapy
    • 批准号:
      22390192
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2010
    • 负责人:
      NAOE Tomoki
    • 依托单位:
    Molecular mechanisms and therapeutic approach of residual leukemia
    • 批准号:
      19390261
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2007
    • 负责人:
      NAOE Tomoki
    • 依托单位:
    海外基金